Actively Recruiting

Age: 12Years +
All Genders
Healthy Volunteers
NCT06819969

The Canadian Lung Outcomes in Users of Vaping Devices Study

Led by University of British Columbia · Updated on 2026-03-30

500

Participants Needed

8

Research Sites

231 weeks

Total Duration

On this page

Sponsors

U

University of British Columbia

Lead Sponsor

B

BC Children's Hospital Research Institute

Collaborating Sponsor

AI-Summary

What this Trial Is About

Vaping is increasingly popular with both adolescent and adult Canadians, but the long-term health impacts remain unknown. We believe that the tools we currently have to detect lung disease in people who vape may be insufficient and propose new ways to find lung injuries that may impact them over the course of their lives. These include exercise testing, new imaging techniques, and new breathing tests that will demonstrate how vaping may harm their lungs. We will use these tools in both adolescent and adult Canadians to give Canadians who vape important information on the consequences of vaping.

CONDITIONS

Official Title

The Canadian Lung Outcomes in Users of Vaping Devices Study

Who Can Participate

Age: 12Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Adolescents aged 12 to under 19 years who either do not use combustible cigarettes or e-cigarettes, or use e-cigarettes only
  • Adults aged 19 years and older who either do not use combustible cigarettes or e-cigarettes, or use combustible cigarettes only, or use e-cigarettes only, or use both combustible cigarettes and e-cigarettes currently
Not Eligible

You will not qualify if you...

  • Contraindication to pulmonary function testing and cardiopulmonary exercise testing
  • Smoked combustible cannabis within the last month or have a history of more than 1 joint-year of combustible cannabis use
  • For adolescents: smoked combustible cigarettes within the last 6 months
  • For adolescents: diagnosed with chronic lung disease such as asthma, cystic fibrosis, or bronchopulmonary dysplasia
  • For adults: currently undergoing treatment for lung cancer
  • Inability to provide written informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 8 locations

1

University of Alberta (Clinical Sciences Building)

Edmonton, Alberta, Canada, T6G 2B7

Actively Recruiting

2

BC Cancer Agency

Vancouver, British Columbia, Canada, V5Z 4E6

Actively Recruiting

3

BC Children's Hospital Research Institute

Vancouver, British Columbia, Canada, V6H 3N1

Actively Recruiting

4

St. Paul's Hospital

Vancouver, British Columbia, Canada, V6Z 1Y6

Actively Recruiting

5

McMaster University (Research Institute of St. Joe's Hamilton)

Hamilton, Ontario, Canada, L8N 4A6

Not Yet Recruiting

6

University of Ottawa (The Ottawa Hospital General Campus)

Ottawa, Ontario, Canada, K1H 8L6

Actively Recruiting

7

University of Toronto (The Hospital for Sick Children)

Toronto, Ontario, Canada, M5G 1E8

Not Yet Recruiting

8

Université de Sherbrooke

Sherbrooke, Quebec, Canada, J1N 3C6

Not Yet Recruiting

Loading map...

Research Team

J

Janice Leung, MD

CONTACT

P

Paloma Burns, MSc

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here